SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,863 | -96.8% | 825 | -95.7% | 0.00% | – |
Q2 2023 | $88,252 | -88.9% | 18,979 | -89.0% | 0.00% | -100.0% |
Q1 2023 | $795,245 | +125.3% | 172,131 | +293.9% | 0.00% | – |
Q4 2022 | $353,048 | +4943.5% | 43,694 | +3271.5% | 0.00% | – |
Q3 2022 | $7,000 | -66.7% | 1,296 | -67.1% | 0.00% | – |
Q2 2022 | $21,000 | -91.1% | 3,939 | -86.3% | 0.00% | – |
Q1 2022 | $236,000 | -78.2% | 28,671 | -60.7% | 0.00% | -100.0% |
Q4 2021 | $1,085,000 | +35.1% | 72,942 | +71.6% | 0.00% | – |
Q3 2021 | $803,000 | -68.6% | 42,505 | -69.1% | 0.00% | -100.0% |
Q2 2021 | $2,558,000 | -33.7% | 137,601 | -18.9% | 0.00% | 0.0% |
Q1 2021 | $3,860,000 | +255.8% | 169,594 | +239.4% | 0.00% | +100.0% |
Q4 2020 | $1,085,000 | +8246.2% | 49,971 | +3913.7% | 0.00% | – |
Q3 2020 | $13,000 | -23.5% | 1,245 | -44.0% | 0.00% | – |
Q2 2020 | $17,000 | -45.2% | 2,225 | -27.5% | 0.00% | – |
Q1 2020 | $31,000 | +29.2% | 3,069 | +40.7% | 0.00% | – |
Q4 2019 | $24,000 | +166.7% | 2,182 | +119.7% | 0.00% | – |
Q3 2019 | $9,000 | -71.9% | 993 | -64.9% | 0.00% | – |
Q2 2019 | $32,000 | +68.4% | 2,830 | +66.2% | 0.00% | – |
Q1 2019 | $19,000 | +18.8% | 1,703 | +1.1% | 0.00% | – |
Q4 2018 | $16,000 | – | 1,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |